Like Zhong

838 total citations
43 papers, 684 citations indexed

About

Like Zhong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Like Zhong has authored 43 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Like Zhong's work include Cancer-related molecular mechanisms research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Like Zhong is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Like Zhong collaborates with scholars based in China, United States and Singapore. Like Zhong's co-authors include Ping Huang, Luo Fang, Roni J. Bollag, Feng Qin, Paul D. Phillips, H Rasmussen, Anthony L. Mulloy, Ke Ding, Richard S. Cameron and Qing Peter Wild Zhong and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Like Zhong

39 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Like Zhong China 12 422 147 139 132 85 43 684
Yoshimi Aizaki Japan 11 319 0.8× 91 0.6× 63 0.5× 90 0.7× 23 0.3× 17 725
Qinyi Zhou China 15 424 1.0× 129 0.9× 264 1.9× 85 0.6× 143 1.7× 30 894
Lei Xie China 17 392 0.9× 92 0.6× 145 1.0× 170 1.3× 79 0.9× 50 809
Timo Frömel Germany 17 521 1.2× 146 1.0× 338 2.4× 41 0.3× 64 0.8× 30 987
Qingqi Meng China 16 371 0.9× 25 0.2× 131 0.9× 45 0.3× 75 0.9× 59 764
Minxiang Lei China 14 303 0.7× 117 0.8× 77 0.6× 32 0.2× 124 1.5× 28 610
In Hee Lee South Korea 14 424 1.0× 43 0.3× 101 0.7× 182 1.4× 77 0.9× 55 920
Yuanyuan Xie China 14 221 0.5× 45 0.3× 72 0.5× 101 0.8× 31 0.4× 49 656
Sofia Bellou Greece 12 288 0.7× 53 0.4× 75 0.5× 48 0.4× 116 1.4× 17 615
Jianning Zhang China 18 647 1.5× 102 0.7× 185 1.3× 47 0.4× 49 0.6× 34 985

Countries citing papers authored by Like Zhong

Since Specialization
Citations

This map shows the geographic impact of Like Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Like Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Like Zhong more than expected).

Fields of papers citing papers by Like Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Like Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Like Zhong. The network helps show where Like Zhong may publish in the future.

Co-authorship network of co-authors of Like Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Like Zhong. A scholar is included among the top collaborators of Like Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Like Zhong. Like Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Like, et al.. (2025). CIDTL: A Cross-In Domain Transfer Learning Model for Vehicular Trajectory Prediction Under Few-Shot Conditions of Aggressive Driving Behavior. IEEE Transactions on Intelligent Transportation Systems. 26(11). 19508–19521. 1 indexed citations
2.
Xin, Wenxiu, Junfeng Zhu, Like Zhong, et al.. (2025). Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(11). 764–773.
3.
Zhu, Junfeng, et al.. (2025). Identification and validation of PANoptosis-related LncRNAs prognosis system in hepatocellular carcinoma. Scientific Reports. 15(1). 6030–6030. 2 indexed citations
4.
Zhang, Haoyu, Like Zhong, & Xiqun Chen. (2025). Multi-strategy coupled active traffic management based on multi-agent reinforcement learning. Journal of Control and Decision. 12(6). 960–975.
5.
Chen, Siqi, Chenchen Jiang, Yan Feng, et al.. (2025). Validated target-based network pharmacology reveals that salvianolic acid C attenuates doxorubicin-induced cardiotoxicity by regulating apoptosis and oxidative stress. Biochemical and Biophysical Research Communications. 775. 152196–152196. 2 indexed citations
6.
7.
8.
Zhong, Like, et al.. (2023). A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma. Journal of Oncology. 2023. 1–18. 5 indexed citations
9.
Zhong, Like, et al.. (2023). Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma. Cellular and Molecular Biology. 69(8). 1–8. 5 indexed citations
10.
She, Han, et al.. (2023). Construction and validation of a mitochondria-associated genes prognostic signature and immune microenvironment characteristic of sepsis. International Immunopharmacology. 126. 111275–111275. 6 indexed citations
11.
She, Han, et al.. (2023). Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis. Frontiers in Immunology. 14. 1184126–1184126. 25 indexed citations
12.
Zhong, Like, et al.. (2023). Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer. Cancer Chemotherapy and Pharmacology. 92(3). 181–192. 3 indexed citations
13.
Ding, Haiying, et al.. (2022). Methadone switching for refractory cancer pain. BMC Palliative Care. 21(1). 191–191. 6 indexed citations
14.
Fang, Luo, Yiwen Zhang, Zongfu Pan, et al.. (2021). Comparison of Proteomics Profiles Between Xenografts Derived from Cell Lines and Primary Tumors of Thyroid Carcinoma. Journal of Cancer. 12(7). 1978–1989. 3 indexed citations
15.
Xiang, Xueping, Xiaojing Ma, Fang Mao, et al.. (2019). Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapy. Translational Cancer Research. 8(7). 2535–2542. 1 indexed citations
16.
Xiang, Xueping, et al.. (2019). Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapy. Translational Cancer Research. 8(7). 2535–2542. 4 indexed citations
17.
Fang, Luo, Wenxiu Xin, Haiying Ding, et al.. (2016). Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis. Scientific Reports. 6(1). 25913–25913. 17 indexed citations
18.
Ying, Meidan, Xinglu Zhou, Like Zhong, et al.. (2012). Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All- Trans -Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis. Molecular Cancer Therapeutics. 12(2). 195–206. 36 indexed citations
19.
Lou, Siyue, Like Zhong, Xiaochun Yang, et al.. (2012). Efficacy of all-trans retinoid acid in preventing nickel induced cardiotoxicity in myocardial cells of rats. Food and Chemical Toxicology. 51. 251–258. 13 indexed citations
20.
Bollag, Roni J., Qing Peter Wild Zhong, Paul D. Phillips, et al.. (2000). Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors1. Endocrinology. 141(3). 1228–1235. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshimi Aizaki Breakdown of academic impact, for papers by Qinyi Zhou Breakdown of academic impact, for papers by Lei Xie Breakdown of academic impact, for papers by Timo Frömel Breakdown of academic impact, for papers by Qingqi Meng Breakdown of academic impact, for papers by Minxiang Lei Breakdown of academic impact, for papers by In Hee Lee Breakdown of academic impact, for papers by Yuanyuan Xie Breakdown of academic impact, for papers by Sofia Bellou Breakdown of academic impact, for papers by Jianning Zhang
Rankless by CCL
2026